All Stories

  1. An iterative method to protect the type I error rate in bioequivalence studies under two‐stage adaptive 2×2 crossover designs

    Article • Biometrical Journal, October 2020, Wiley

    Eduard Molins Lleonart

  2. An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2019, Taylor & Francis

    Eduard Molins Lleonart

  3. AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2019, Dove Medical Press

    Eduard Molins Lleonart

  4. Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT

    Article • International Journal of Chronic Obstructive Pulmonary Disease, February 2019, Dove Medical Press

    Eduard Molins Lleonart

  5. ACTIVATE: effect of aclidinium/formoterol on physical activity in patients with COPD

    Article • September 2017, European Respiratory Society (ERS)

    Eduard Molins Lleonart

  6. Two‐stage designs versus scaled average designs in bioequivalence studies for highly variable drugs.

    Article • Statistics in Medicine, August 2017, Wiley

    Professor Jordi Ocaña, Eduard Molins Lleonart

  7. A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease

    Article • Respiratory Medicine, April 2017, Elsevier

    Eduard Molins Lleonart

  8. Long-term costs of colorectal cancer treatment in Spain

    Article • BMC Health Services Research, February 2016, Springer Science + Business Media

    Eduard Molins Lleonart

  9. Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)

    Article • August 2015, Springer Science + Business Media

    Eduard Molins Lleonart

  10. Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study

    Article • BMC Pulmonary Medicine, November 2014, Springer Science + Business Media

    Eduard Molins Lleonart

  11. Evaluation of the Efficacy and Safety of Two Doses of Aclidinium and Formoterol in Fixed-Dose Combination in Patients With COPD: The ACLIFORM Study

    Article • CHEST Journal, March 2014, Elsevier

    Eduard Molins Lleonart

  12. Inter- and intraradiologist variability in the BI-RADS assessment and breast density categories for screening mammograms

    Article • British Journal of Radiology, November 2012, British Institute of Radiology

    Eduard Molins Lleonart

  13. Effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme

    Article • Public Health, September 2009, Elsevier

    Eduard Molins Lleonart

  14. Association between Radiologists' Experience and Accuracy in Interpreting Screening Mammograms

    Article • BMC Health Services Research, April 2008, Springer Science + Business Media

    Eduard Molins Lleonart

  15. Evaluation of hand hygiene adherence in a tertiary hospital

    Article • American Journal of Infection Control, December 2007, Elsevier

    Eduard Molins Lleonart

  16. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme

    Article • Journal of Epidemiology & Community Health, April 2006, BMJ

    Eduard Molins Lleonart